New aspects of malaria imported from Ethiopia

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1089-1091

  Schwartz, Eli ^a   Sidi, Yechezkel ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; MEFLOQUINE; PRIMAQUINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHIOPIA; HUMAN; INCIDENCE; MALARIA; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; RELAPSE; TRAVEL;

EID: 0031925962     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520279     Document Type: Article

References (15)

1. Miller LH, Mason SJ, Clyde DF, McGinnis MH. The resistance factor to Plasmodium vivax in blacks. N Engl J Med 1976;295:302-4.
2. Mathews HM, Armstrong JC. Duffy blood types and vivax malaria in Ethiopia. Am J Trop Med Hyg 1981;30:299-303.
3. Zein AZ, Kloos H. The ecology of health and disease in Ethiopia. Addis Ababa, Ethiopia: Ministry of Health, 1988.
4. White GB. Anopheles gambiae complex and disease transmission in Africa. Trans R Soc Trop Med Hyg 1974;68:278-96.
5. The clinical management of acute malaria. South-East Asia series no. 9. New Delhi, India: WHO Regional Publications, 1990:135.
6. Clyde DF, McCarthy VC. Radical cure of Chesson strain vivax malaria in man by 7, not 14 days of treatment with primaquine. Am J Trop Med Hyg 1977;26:562-3.
7. David PH, del Portillo HA, Mendis KM. Plasmodium vivax malaria: parasite biology defines potential targets for vaccine development. Biol Cell 1988;64:251-60.
8. Arnold J, Alving AS, Hockwald RS, et al. The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. J Lab Clin Med 1954;44:429-38.
9. Arnold J, Alvin AS, Hockwald RS, et al. Natural history of Korean vivax malaria after deliberate inoculation of human volunteers. J Lab Clin Med 1954;44:723-6.
10. Wyler DJ. Malaria chemoprophylaxis for the traveler. N Engl J Med 1993;329:31-7.
11. Bradley DJ, Warhurst DC. Malaria prophylaxis: guidelines for travellers from Britain. BMJ 1995;310:709-14.
12. Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991;45:86-91.
13. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996;113:525-8.
14. Weiss WR, Oloo AJ, Johnson A, et al. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus porguanil. J Infect Dis 1995;171:1569-75.
15. Fryauff DJ, Baird JK, Basri H, et al. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995;346:1190-3.